Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001209191-13-014691)

Filing Details

Accession Number:: 0001209191-13-014691
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-03-06 19:02:58
Reporting Period:: 2013-03-05

Filing Date:: 2013-03-06
Accepted Time:: 2013-03-06 19:02:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1100962	Endo Health Solutions Inc.	ENDP	Pharmaceutical Preparations (2834)	134022871

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1251968	David Nash	4071 Oak Lane Lafayette Hill PA 19444		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value, $0.01 Per Share	Acquisiton	2013-03-05	670	$30.80	10,411	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

This represents the market price per share of Dr. Nash's common stock purchases on March 5, 2013.
This number represents (i) 4,930 shares of common stock, 4,260 of which have been deferred under the Endo Health Solutions Directors Deferred Compensation Plan and (ii) 5,481 restricted stock units.